While many recent meta-analyses revealed a strong association of high levels of certain adipokines (adiponectin, leptin) with breast cancer, inter-population variability may limit its generalizability as a biomarker for disease prognosis and progression. This evidence concerns the gene ADIPOQ and breast cancer.